Nektar Therapeutics Statistics

Total Valuation

LON:0UNL has a market cap or net worth of GBP 808.49 million. The enterprise value is 730.16 million.

Market Cap	808.49M
Enterprise Value	730.16M

Important Dates

The last earnings date was Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	19.02M
Shares Outstanding	n/a
Shares Change (YoY)	+14.07%
Shares Change (QoQ)	+34.49%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	44.46%
Float	17.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.36
PB Ratio	12.77
P/TBV Ratio	12.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.13
EV / Sales	15.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.24, with a Debt / Equity ratio of 1.96.

Current Ratio	4.24
Quick Ratio	4.07
Debt / Equity	1.96
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.13

Financial Efficiency

Return on equity (ROE) is -180.24% and return on invested capital (ROIC) is -33.61%.

Return on Equity (ROE)	-180.24%
Return on Assets (ROA)	-27.97%
Return on Invested Capital (ROIC)	-33.61%
Return on Capital Employed (ROCE)	-58.03%
Revenue Per Employee	763,453
Profits Per Employee	-1.47M
Employee Count	61
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	-318,406
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +171.33% in the last 52 weeks. The beta is 0.58, so LON:0UNL's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+171.33%
50-Day Moving Average	54.23
200-Day Moving Average	27.87
Relative Strength Index (RSI)	47.56
Average Volume (20 Days)	5,641

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0UNL had revenue of GBP 46.57 million and -89.82 million in losses. Loss per share was -5.88.

Revenue	46.57M
Gross Profit	40.64M
Operating Income	-101.45M
Pretax Income	-90.14M
Net Income	-89.82M
EBITDA	-100.72M
EBIT	-101.45M
Loss Per Share	-5.88

Full Income Statement

Balance Sheet

The company has 201.02 million in cash and 124.30 million in debt, giving a net cash position of 76.72 million.

Cash & Cash Equivalents	201.02M
Total Debt	124.30M
Net Cash	76.72M
Net Cash Per Share	n/a
Equity (Book Value)	63.30M
Book Value Per Share	3.34
Working Capital	159.96M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 87.26%, with operating and profit margins of -217.83% and -192.87%.

Gross Margin	87.26%
Operating Margin	-217.83%
Pretax Margin	-193.55%
Profit Margin	-192.87%
EBITDA Margin	-216.28%
EBIT Margin	-217.83%
FCF Margin	n/a

Dividends & Yields

LON:0UNL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.07%
Shareholder Yield	-14.07%
Earnings Yield	-11.11%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 9, 2025. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Jun 9, 2025
Split Type	Reverse
Split Ratio	0.0666666667

Scores

Altman Z-Score	n/a
Piotroski F-Score	3